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Abstract. Fluorescence-based single molecule techniques to interrogate gene expression in tissues present a
very low signal-to-noise ratio due to the strong autofluorescence and other background signals from tissue sec-
tions. This report presents a background-free method using second-harmonic generation (SHG) nanocrystals as
probes to quantify the messenger RNA (mRNA) of human epidermal growth receptor 2 (Her2) at single molecule
resolution in specific phenotypes at single-cell resolution directly in tissues. Coherent SHG emission from indi-
vidual barium titanium oxide (BTO) nanoprobes was demonstrated, allowing for a stable signal beyond the auto-
fluorescence window. Her2 surface marker and Her2 mRNA were specifically labeled with BTO probes, and
Her2 mRNA was quantified at single copy sensitivity in Her2 expressing phenotypes directly in cancer tissues.
Our approach provides the first proof of concept of a cross-platform strategy to probe tissues at single-cell res-
olution in situ. © 2015 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.20.9.096016]
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1 Introduction
It has been well documented that variation in the transcription of
key genes triggers the loss of homeostasis in tissues, and the
profile development of different gene expression, such as human
epidermal growth receptor 2 (Her2), contributes to cellular
heterogeneity within individual breast cancer tumors.1–3 To bet-
ter prevent and treat breast cancer, it is necessary to screen for
the expression of critical genes, for example Her2, of patients
undergoing specific treatments. In addition to the conventional
molecular biology-based approaches, fluorescence in situ
hybridization (FISH)4,5 approaches are on the rise for the detec-
tion of genomic constituents at close to single molecule sensi-
tivity. However, fluorescence-based detection methods are
restrictive when interrogating tissues. First, fluorescence micros-
copy is limited by the photon emissive property of the fluores-
cent probes,6 such as fluorescent proteins, fluorescent dyes, and
even quantum dots (QDs).7 These probes are prone to photo-
bleaching or saturation upon exposure to a laser beam with
high power for a prolonged period, therefore, they not conducive
for quantitative detection.8–11 Second, the fluorescent signal
from a single molecule is usually overwhelmed by the laser-
induced autofluorescence from tissues or live organs.12,13 In
this scenario, it is urgent to develop nonfluorescent approaches
for tissue imaging. Recently, Raman and plasmonic approaches
are proposed utilizing the strengths of Raman or dark-field
microscopy for cellular imaging.14–16 However, the scattering
from cellular components is much higher than the signal from
individual Raman or plasmonic probes since the scattering cross
section is proportional to the volume squared,17 eliminating the
possibility of tissue analysis due to low signal-to-noise ratio
(SNR) using these techniques.
To circumvent the disadvantages of fluorescent and plas-
monic approaches, inorganic nanocrystals with second-har-
monic generation (SHG), i.e., laser frequency doubling, have
recently been used as probes for biolabeling and imaging.18–22
SHG is a nonlinear optical process which converts two incident
photons at a frequency ω into one photon at frequency 2ω in a
noncentrosymmetrical material.23 Unlike fluorescence, the SHG
process only involves the transition between virtual energy
states without any nonradiative loss. Therefore, under the illu-
mination of an ultrafast near-infrared (NIR) laser, the SHG
material emits transient, high intensity, nonblinking, nonbleach-
ing, and unsaturated light pulses with an ultranarrow bandwidth
(<5 nm).22 SHG nanocrystals, such as barium titanium oxide
(BaTiO3, BTO), lithium niobate (LiNbO3), potassium titanyl
phosphate (KTiOPO4, KTP), and lithium triborate (LiB3O5,
LBO), have been used to detect single molecules with a regular
and holographic second-harmonic imaging microscopy (SHIM)
19–22,24 and correlation spectroscopy.25,26 Compared with fluo-
rescence probes, the SHG emission is free from saturation and
bleaching, and has an intense and stable output with a narrow
spectral window, where the environmental autofluorescence can
be minimized to be background-free for analysis of optically
challenging samples such as tissues.
This work will show the utility of SHG nanocrystals, BTO,
as probes for quantifying Her2 messenger RNA (mRNA) in
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breast cancer tissues in Her2 expressing cells at the single mol-
ecule sensitivity. BTO nanocrystals were subsequently modified
with a cell surface marker targeting antibodies or oligonucleotides
that target the Her2 mRNA using appropriate functionalization
protocols and the subcellular localization patterns in single
cells were elucidated in breast tissues with high sensitivity.
2 Experiments
2.1 BaTiO3 Nanocrystal Functionalization and
Conjugation
Figure 1 shows the schematic of the chemical functionalization
and bioconjugation of BTO nanocrystals with antibodies and
oligonucleotides. Dried powders of BTO nanocrystals were sup-
plied by the Bowen (Swiss Federal Institute of Technology,
Lausanne, Switzerland).27 Dried powder was first dissolved in
water in the ratio of 10 mg to 100 mL and sonicated for 20 min
to obtain monodispersed nanocrystals; aggregates were excluded
by multiple filtrations through 0.2 μm-pore filter membranes.
The prepared BTO nanocrystals were immersed in 1 M of sul-
furic acid for 10 min to remove the surface barium ions and
the supernatant was discarded after centrifugation (6500 rpm,
20 min). The surface-activated BTO was then reacted with
0.1% 3-triethoxysilylpropylamine (APTES) dissolved in anhy-
drous ethanol at 70°C for 2 h to functionalize the surfaces with
amine groups. After removing the unreacted APTES by cen-
trifugation, nanocrystals were mixed with 2 mM of succinimidyl
4-[N-maleimidomethyl]cyclohexane-1-carboxylate, dissolved
in dimethyl sulfoxide, and kept at room temperature for 1 h.
Herceptin (trastuzumab) monoclonal antibodies were kindly
provided by Genentech Inc. (San Francisco, California). Herceptin
was first reduced by 10-mM DL-Dithiothreitol (DTT) and then
purified by Sephadex G-15 column chromatography (10 mL
volume). BTO nanocrystal–herceptin conjugation was realized
by coupling at room temperature for 1 h. The residual surfaces
were finally blocked with 10 mM mercaptoethanol.
The oligonucleotide strand was designed using NCBI Blast
and was purchased from IDT-DNA, Inc. Coralville, Iowa. 5’-
end thiolated (capture strand) oligonucleotides were used for
conjugation with BTO nanocrystals. The sequence of the oligo-
nucleotide is listed below:
5′-AGAACTGAGATGAGGTGGGGttttttttttC3-3′-/ThiolM/
The disulfide bond of thiolated oligonucleotide was first dis-
rupted using a 10 mM solution of tris(2-carboxyethyl)phosphine
hydrochloride. The reduced thiolated DNA strands (1 μM) were
then reacted with functionalized (thiol-reactive) 1 mL of BTO
nanocrystals solution to obtain a 1 mL of DNA-BTO conjugate
solution (at ∼60°C for 30 min to 1 h). The residual surfaces were
finally blocked with 10 mM mercaptoethanol and the unbound
oligonucleotides were washed away with 0.3 M phosphate buf-
fered saline (PBS).
2.2 Tissue Processing
Human breast cancer tissues (1 cm × 1 cm) deposited on cover
slides were obtained from surgical leftovers from patients at the
Indiana University, School of Medicine; 24 slides in total were
used in our study. Tissue slides were first deparaffinized by
immersing paraffin-embedded tissues in xylenes (histological
grade xylene, Fisher Scientific) for 5 min, three times. The slides
were then rehydrated in a series of ethanol (Pharmco-AAPER)
gradient; 100%, 95%, and 80% each two times, 10 min each.
Next, the slides were washed in deionized H2O for 1 min, and
the excess solution outside the tissue section was aspirated using
tissue papers. Subsequently, rehydrated tissue slides were per-
meabilized with 0.1% Tween 20 (Sigma) in tris-buffered saline
1× (BioRad). Antigen retrieval was performed by immersing
tissue slides in 10-mM Sodium citrate buffer, pH 6, at 90°C
for 30 min, and transferred into a cold 10 mM, pH 6, sodium
citrate buffer and allowed to cool for 20 min, then were washed
in deionized water three times. To prevent nonspecific binding,
the slides were treated with goat kit blocking solution for 60 min
and washed with PBS three times. The slides were then incu-
bated with antibody-BTO conjugates or oligonucleotide-BTO
conjugates overnight on the shaker to ensure the binding of
probes to the surface marker or mRNA. Finally, the sections
were washed in PBS three times for 5 min and imaged with the
second harmonic imaging microscopy described below.
2.3 Second-Harmonic Imaging Microscopy
The SHIM was constructed based on a customized time-corre-
lated scanning multiphoton microscopy.28 A Chameleon Ultra
Ti-Sapphire tunable laser (Coherent Inc., California) operating
in the range from 680 to 1080 nm was used as excitation. The
laser beam was delivered onto the sample by a water-immersion
Fig. 1 Schematic of barium titanium oxide (BTO) functionalization of nanocrystals (middle) and their
conjugation with a herceptin antibody (upper) and oligonucleotide (down). See methods section for a
detailed description.
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objective (60× /1.20 NA, Olympus). Emitted photons were reg-
istered in a time-tagged-time-resolved mode by single-photon
avalanche photodiodes (SPCM-AQR-14, PerkinElmer Inc.)
after filtration. The polarization response of the SHG signal was
recorded by rotating a half-wave plate (10RP52-2, Newport) on
the propagation path of the incident beam. The spectrum was
recorded by a cooled-spectrometer (QE65000, Ocean Optics
Inc.). Fluorescence and SHG images were further processed in
ImageJ and MATLAB®.26
3 Results and Discussions
3.1 Characterization of Barium Titanium Oxide
Nanocrystals
The BTO nanocrystals were first investigated by characterizing
their physical and optical properties. It is critical to control the
monodispersibility of BTO nanocrystals in solutions, not only to
ensure that the antibody or oligonucleotide is able to bind to
individual BTO nanocrystals, but also to avoid the polycrystal-
line BTO aggregates which have a significant influence on the
SHG properties.29 Details of the chemical functionalization of
BTO nanocrystals are provided in the experimental section. 30
Essentially, the surface of the nanocrystals was first coated
with amino groups to avoid aggregation (Fig. 1), then a malei-
mide group was added for future antibody/oligonucleotide con-
jugation. The dispersibility of the BTO colloidal suspension
[Fig. 2(a), inset] was evaluated by dynamic light scattering,
as shown in the inset of Fig. 2(b). It can be observed that
BTO nanocrystals are monodispersed in solutions with an aver-
age hydrodynamic diameter of about 86.81 21.58 nm. This
conclusion was further supported by characterizing BTO nano-
crystals spin coated on a coverslip and examined by scanning
electron microscopy [Fig. 2(a)]. The size statistics of BTO nano-
crystals suggest that the average diameter is 70.30 17.03 nm.
This size provides a balance between cellular penetration and
signal strength which depends on the size of the individual
nanocrystals.20
The optical properties of individual BTO nanocrystals,
deposited on a coverslip, were characterized by a customized
multiphoton scanning microscopy. Details of the instrument can
be found in the experimental section and our previous work.26
Figure 3(a) shows a typical confocal scanning image of BTO
nanocrystals deposited on the coverslip, and the temporal
response is indicated in Fig. 3(b), which is compared with
the decay curve of autofluorescence from tissues. The strong
SHG signal from individual BTO nanocrystals suggests an ultra-
high SNR (>105), while the average laser intensity applied on
the nanocrystal was about 49.5 KW∕cm2, which is several
orders of magnitude lower than the tissue damage threshold.31
In addition, the response of the SHG signal is transient, in the
range of femtoseconds,23 which is beyond the detection capabil-
ity of our instrument. In Fig. 3(b), the fittings suggest that the
lifetime of the SHG signal is 0.21 ns, which is the instrument
response time, while the lifetime of autofluorescence of the tis-
sue is 2.38 ns. More importantly, SHG emission from BTO
nanocrystals yields a discrete peak at 441.6 nm when being illu-
minated at 883 nm, and the full width at half maximum
(FWHM) of the SHG signal (3.9 nm) is half of the FWHM
of the incident laser beam (8.6 nm). It should be noted that
the SHG emission of the nanoscale BTO crystals is generally
a nonresonant process, which offers flexible tunability of the
excitation wavelengths. In Fig. 3(c), we show the emission spec-
tra of the SHG signal from BTO nanocrystals excited by differ-
ent wavelengths, where the emission intensity agrees well with
the corresponding absorption coefficient [Fig. 3(c), inset].
The unusual optical response of the BTO nanocrystals per-
mits several methods to distinguish SHG signals from autofluor-
escence in cells or tissues. The autofluorescent emission in cells
or tissues mostly originates from the aromatic amino acids, lipo-
pigments, pyridinic (NAD, NADH, and NADPH), and flavin
coenzymes.12 In addition to the cellular components, extracel-
lular matrix, such as collagen and elastin, also has a significant
contribution to the autofluorescence of tissues.12 Under two-
photon excitation, the autofluorescence from these cellular com-
ponents and the extracellular matrix has a broad emission spec-
trum with the minimum wavelength larger than half of the
excitation wavelength, and a broad range of fluorescence life-
time (∼ few nanoseconds) [Fig. 3(b)]. Therefore, we can use
Fig. 2 Physical characterization of BTO nanocrystals: (a) scanning
electron microscopy (SEM) image of BTO nanocrystals deposited
on a coverslip. Inset is an optical image of the colloidal suspension.
(b) Size histogram of BTO nanocrystals investigated by SEM. Inset:
histogram of the size distribution of BTO suspension by dynamic light
scattering (DLS) analysis.
Fig. 3 Second-harmonic generation (SHG) from individual BTO
nanocrystals. (a) Typical confocal scanning image of individual nano-
crystals. (b) Time-resolved single-photon counting histogram sug-
gests transient response of SHG signal compared with the auto-
fluorescence from tissues. (c) Emission spectra recorded for 883,
923, and 953 nm excitation wavelengths. Left inset: absorption spec-
trum of BTO colloidal solutions; right inset: spectrum of excitation
laser beam at 883 nm. (d) Polarization responses along the X and
Y transverse axes of individual BTO nanocrystals in (a). Dots: exper-
imental measurements; lines: theoretical fittings.
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spectral filtration and/or lifetime filtration to achieve single mol-
ecule detection with a high SNR. A narrow bandpass (∼5 nm)
filter with the center wavelength of λ∕2 can be used to block
autofluorescence. Further, the lifetime analysis can identify dif-
ferent signals with significant lifetime differences.32 Since the
lifetime of the SHG signal is several orders of magnitude smaller
than the lifetime of the autofluorescence (experimentally, the
lifetime of the SHG signal is limited by the instrument response
time), the combination of the lifetime filtration and spectral fil-
tration has high potential to detect individual SHG nanocrystals
in live organs or tissues which have significantly inherent
autofluorescence.
Another important and unique property of SHG emission
from BTO nanocrystals is that the SHG signal has different
responses to the polarization angle of the incident laser beam.
A single nanocrystal of subwavelength size can be regarded as a
dipole oscillating along the c-axis of the crystal structure.33 As
shown in Fig. 3(d), we observed a dipolar-type response of the
SHG intensity along the X and Y transverse axes when rotating
the linear polarization along the XY plane. This observation is a
clear signature of the single crystalline structure of the BTO
nanocrystals, and the polarization analysis of the SHG signal
is a powerful tool to revoke the three-dimensional (3-D) orien-
tation of the crystal structure.29 This feature suggests a possible
approach to identify the SHG signal of specific nanocrystals
from the backscattered endogenous SHG signal from the tissue
matrix protein, such as collagen.34 At first, the BTO nanocrystal
has larger second-order susceptibility than the collagen has;35,36
in our experiments, SHG signals from the nanoprobes are about
50 to 200 times that of the signal from tissues or cells. In addi-
tion, the collagen often consists of matrix proteins, which is an
ordered structure where the SHG signal can reach the maximum
at a single polarization angle of the excitation beam. In com-
parison, the spatial orientation of the nanocrystal is randomly
distributed in 3-D dimension, and there is very minimum pos-
sibility that the nanocrystal and collagen have overlapped dipole
orientation. The SHG signal from the nanocrystal and collagens
can be significantly differentiated by excitation at different
polarization angles.
3.2 Screening of Transcripts in Tissues
Given the unique optical properties of BTO nanocrystals, we
further applied this bioprobe for quantitative analysis of mRNA
in tissues. Most of the currently reported biological applications
of SHG nanocrystals have focused on exploring the new imag-
ing modalities of nonspecific cell uptake in different biological
models;18,37,38 in our work, we focused our attention on the util-
ity of the nanocrystals as probes to detect surface markers and
transcripts of the Her2 gene at single particle sensitivity in tis-
sues. It has widely been accepted that the Her2 gene is associ-
ated with the tumorigenesis of breast cancer, where the Her2
proteins form clusters in cell membranes. Herceptin (trastuzu-
mab) is a monoclonal antibody that targets the extracellular
domain of the Her2 receptor, and is an accepted therapeutic
for breast cancer treatments and a targeting ligand for diagno-
sis.1 The targeting of Herceptin and the corresponding imaging
of the Her2 protein provide information on the identity of this
cancer stem cell phenotype in tissues, which plays an important
role in the prediction of tumor invasiveness and metastatic
potential.2 Meanwhile, information on the expression level and
localization patterns of Her2 mRNA can pave the way for sin-
gle-cell screening strategies.3 Developing imaging methods for
rigorous quantitative analysis of the Her2 surface marker and
the corresponding transcripts in a tissue context will be crucial
for cancer staging. More specifically through this technology
demonstration, we will provide the tools for single-cell quanti-
fication of genomic components in tissues, a challenging propo-
sition using fluorescence or other methods.
To ensure the specific binding of BTO nanocrystals to the
cell surface markers and transcripts, we conjugated the surface
of chemically treated BTO nanocrystals with disulfide-reduced
herceptin antibody and single-strand oligonucleotide (Fig. 1).
Details of the conjugation can be found in the experimental sec-
tion. First, the binding specificity and biocompatibility of the
conjugated nanoprobes were validated in cultured breast cancer
cell lines, MCF-7 and SK-BR-3. Figure 4 shows the typical
results for detecting Her2 mRNA in SK-BR-3 cells and Her2
surface marker in MCF-7 cells. Unconjugated BTO nanocrys-
tals suggest very limited nonspecific binding on each cell line,
while BTO-oligonucleotide probes were abundantly present in
the cytoplasm of SK-BR-3 cells and indicate the overexpression
of the Her2 genes. Similar results were also reported in our pre-
vious work30 and other publications using FISH approaches.39,40
The binding of BTO-herceptin probes was confirmed by a typ-
ical example in MCF-7 cells, which have been reported to be
positive to herceptin [Fig. 4(b)].8,11 The high specificity of bind-
ing to the Her2 receptor was evident as the observed discrete
spots on the membrane of MCF-7 cells. In addition to Fig. 4,
mRNA detection in MCF-7 cells and surface marker detection
in SK-BR-3 cells can be referred to in our prior work.8,11
Fig. 4 Single molecule detection using BTO nanocrystals in cells.
(a) in vitro detection of Her2 mRNA in SK-BR-3 cells using chemically
modified BTO (upper) and BTO-oligonucleotide conjugates (down).
(b) in vitro detection of Her2 protein in MCF-7 cells using chemically
modified BTO (upper) and BTO-herceptin conjugates (down). Left
panel: two-photon autofluorescence imaging of cells; middle panel:
SHG imaging of BTO nanocrystals; right panel: merged image of
the previous two panels.
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In this presentation, SHG nanocrystals were first utilized to
identify specific phenotypes based on the surface marker expres-
sion levels and directly quantify the corresponding transcript
cells within tissues. Patient tissue slides were treated with func-
tionalized BTO probes to target cell surface markers and mRNA
of Her2 to quantitate the expression of transcripts in specific
phenotypes at single-cell resolution. Details of the incubation
and internalization are described in the experimental section.
Meanwhile, 4',6-diamidino-2-phenylindole (DAPI) staining
was also performed to visualize the SHG particles in the nuclei
of cells in tissue. The excitation wavelength for both channels
(SHG and DAPI) was set at 880 nm, while different emission
filters (SHG: 435 to 485; DAPI: 500 to 540) were used to collect
the SHG and DAPI signals. Figure 5 shows the localization of a
Her2 surface marker by targeting BTO-herceptin conjugates.
From the SHG channel [Figs. 5(b) and 5(e)], one can observe
bright SHG spots depicting the BTO nanocrystals. It should
be noted that there is little bleed through DAPI fluorescence
in the SHG channel due to the relatively broad bandpass filter.
For better imaging performance, the use of narrow band filters
(∼5 nm) is recommended. By overlapping it with the DAPI
image, it can be found that these bright spots localize at the inter-
face between the cells. As a control, chemically functionalized
BTO nanocrystals were incubated with tissues using the same
protocol; as expected, very few SHG spots were observed
from the SHG channel except for some nonspecific bindings.
In addition to detecting surface markers, we also quantified
the Her2 mRNA transcripts in breast cancer tissues, as shown in
Fig. 6. Similar to the FISH approach, each diffraction-limited
spot represents one location of a Her2 mRNA. It can be
observed that the Her2 mRNA not only exists in the cytoplasm
of cells, but also occupies several locations in the nucleus. Since
we found that most mRNA molecules are located within a thin
section (∼5 μm, not shown here), and the collection of SHG
images is from a 2-D section (80 μm × 80 μm), although the
tissue has a 3-D structure. The number of mRNA molecules
was counted with ImageJ and MATLAB according to the
algorithm developed in Ref. 40. It should be noted here that
the quantification of the mRNA molecules in tissues is under-
estimated mainly from two aspects. One is the 2-D imaging and
quantification, and the other is the diffraction limitation. Future
work can focus on applying 3-D super resolution concepts for
detection and quantification of mRNAs in the entire tissue
architecture.
Quantification [Fig. 6(g)] suggests the heterogeneity of Her2
mRNA at the single-cell level in breast cancer tissues. Compared
to the conventional FISH method for mRNA quantification,4,5
SHG probes have several advantages because of their unique
emission with a high SNR. In FISH, several fluorescent report-
ers are labeled along the oligonucleotide probe and multiple
probes are required for a transcript to ensure satisfactory
SNR. The intense and crowded labeling on the transcript results
in the self-quenching of these fluorescent reporters due to
the dye–dye interaction which significantly affects the quantifi-
cation analysis.4 By contrast, in our design of the oligonucleo-
tide-BTO probe (20 to 25 bases), only a single BTO nanocrystal
is needed to target a single transcript due to its high SNR, while
the FISH probes are long sequences and require labeling with
several fluorophores.4 The nanoprobes are capable of hybridiz-
ing to the transcripts with a very broad range of sequences as
long as sequence specificity is ensured for transcript targeting.41
Quantification of mRNA molecules in breast cancer tissues is
much lower than that in SK-BR-3 cells, while it is comparable
to the number in MCF-7 cells,30,39 and is in agreement with pre-
vious publications.42 There is large variation in the expression
level of Her2 in different cell lines. Even in the same tissue, there
is also a significant cell-to-cell variation [Fig. 6(g)]. Such
heterogeneity of the mRNA might play an important role at
the transcriptional as well as the post-translational level,43
and regulates the Her2 receptor expression at the cell surface,
which could provide a therapeutic target for breast cancer.
Together with other molecular biology approaches, the SHG
Fig. 5 Confocal images of breast cancer tissues labeled with BTO-antibody probes. (a)–(c) Tissues were
first incubated with bare BTO nanocrystals as control. (d)–(f) Tissue slides were incubated with herceptin
antibody conjugated with BTO nanocrystals. Two-photon fluorescence images from DAPI used to local-
ize in the nucleus are shown in blue in (a) and (d); SHG images are shown in green in (b) and (e); and
merged images of both channels are shown in (c) and (f).
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imaging concept can be utilized to correlate the expression of
Her2 mRNA and receptors, contributing to the exploration of
potential regulatory pathways that can bridge these two factors.
The nonlinear SHG signal from BTO nanocrystals enables
the detection of individual Her2 genes, by the quantification
of either surface marker or transcript, in highly autofluorescing
patient tissues at a single molecule sensitivity. This nonlinear
imaging method provides a venue for the quantification of
key biomarkers for personalized cancer diagnosis and treatment.
In the early or pre-early stages of triple-negative breast cancer,
the Her2 gene has relatively low-expression levels with a small
variation.3 The BTO nanocrystal and the SHG imaging tool will
provide accurate quantitative information of the Her2 gene.
Furthermore, combined with the second-harmonic super resolu-
tion microscopy,30 more specific surface markers and transcripts
can be resolved in the tissue to assist in the diagnosis of early
stage breast cancer.
Because of the unique photostability of the SHG signal, the
BTO probes and the SHG imaging strategy proposed can be
broadly utilized for background-free imaging and detection of
single molecules in tissues. Key advantages are that the BTO
nanocrystals are not toxic to live cells or live organs, and the
surface functionalization of BTO nanocrystals allows for flex-
ible conjugation with oligonucleotide, antibody, protein, and
even bacteria, showing excellent biocompatibility.19–21 Second,
the SHG property of a BTO nanocrystal is not affected by
chemical modifications or conjugations due to the intrinsic
coherence of the SHG signal. While the fluorescence emission
from dyes or fluorescent proteins is highly influenced by envi-
ronmental factors, such as pH, ion concentration, or surface
chargers.6 The high yield and stable SHG signal guarantees
high SNR from even a single BTO nanocrystal. Last but not
the least, the NIR excitation of the SHG imaging approach
allows for deep tissue imaging and detection, which is hard
for regular one photon confocal microscopy using fluorescent
probes. In our experiment, surface markers and mRNAs were
detected from single cells at an estimated depth of ∼30 μm
in the tissue slides, rendering the technology a highly promising
tool for quantitative detection of single-cell biomarkers at the
protein and the RNA level. The above-mentioned exquisite opti-
cal properties of BTO nanocrystals could allow for the potential
monitoring of biomolecules in live cells. However, to further
validate the application of BTO nanocrystals and SHG imaging
platform for clinical practice, the staining efficiency and speci-
ficity need additional investigations. The BTO nanocrystals
used in this work have an average size of ∼70 nm before bio-
conjugation and ∼100 nm after bioconjugation; the binding effi-
ciency is influenced by the difficulty of penetration through the
tissue due to the size of the probe,44 leading to an underestima-
tion of the quantification. The nonspecific nanoprobes are not
easily washed away. Therefore, there is a need to develop
SHG nanocrystals that are nanometer in size (20 to 40 nm)
that can be used for clinical applications.44 In addition, differ-
entiation of SHG signals from nanoprobes or native tissues, such
as collagen,34 needs further exploration.
4 Conclusion
We report on a highly prospective application of BTO nanocrys-
tals by taking advantage of its strong SHG signal to quantify cell
surface markers and mRNA expression at the single-cell level in
tissue samples. We have specifically functionalized BTO nano-
crystals with antibodies and oligonucleotides, respectively, to
target specific cells and transcripts, and examined the physical
and optical properties of individual BTO nanocrystals, demon-
strating the features such as biocompatibility,20 ultranarrow band
SHG emission, high SNR, and polarimetry response. Quantifi-
cation of the herceptin surface marker and Her2 mRNAs using
BTO nanocrystals has shown the heterogeneity of genomic
expression in clinical tissue slides, providing essential support
and proof of concept toward the development of a quantitative
tool for the diagnosis of cancers in the early stage.
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